RGNX - REGENXBIO Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.91B
Enterprise Value 31.68B
Trailing P/E 19.15
Forward P/E 1-18.40
PEG Ratio (5 yr expected) 1-7.94
Price/Sales (ttm)8.76
Price/Book (mrq)3.71
Enterprise Value/Revenue 37.67
Enterprise Value/EBITDA 618.20

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 45.74%
Operating Margin (ttm)40.32%

Management Effectiveness

Return on Assets (ttm)14.83%
Return on Equity (ttm)28.89%

Income Statement

Revenue (ttm)218.5M
Revenue Per Share (ttm)6.54
Quarterly Revenue Growth (yoy)1,898.90%
Gross Profit (ttm)208.87M
EBITDA 92.08M
Net Income Avi to Common (ttm)99.94M
Diluted EPS (ttm)2.73
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)319.76M
Total Cash Per Share (mrq)8.78
Total Debt (mrq)5.85M
Total Debt/Equity (mrq)1.15
Current Ratio (mrq)15.24
Book Value Per Share (mrq)14.09

Cash Flow Statement

Operating Cash Flow (ttm)104.65M
Levered Free Cash Flow (ttm)59.21M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.04
52-Week Change 335.28%
S&P500 52-Week Change 38.90%
52 Week High 385.10
52 Week Low 335.65
50-Day Moving Average 356.42
200-Day Moving Average 353.91

Share Statistics

Avg Vol (3 month) 3558.2k
Avg Vol (10 day) 3764.4k
Shares Outstanding 536.61M
Float 28.48M
% Held by Insiders 115.70%
% Held by Institutions 183.65%
Shares Short (Mar 29, 2019) 43.52M
Short Ratio (Mar 29, 2019) 45.11
Short % of Float (Mar 29, 2019) 4N/A
Short % of Shares Outstanding (Mar 29, 2019) 49.67%
Shares Short (prior month Feb 28, 2019) 43.25M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A